AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Defined Benefit Pension Plans by Year
Defined Benefit Pension Plans — Projected Benefit Obligation (PBO) [year-end] ($M) ($M)
AbbVie Defined Benefit Pension Plans: $9,658M in FY2025, up 7.7% from a year earlier.
Latest, FY2025
9,658
Period ended Dec 31, 2025
Change on a year earlier
+7.7%
8,964 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-K Note 12 Post-Employment Benefits.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Defined Benefit Pension Plans — Projected Benefit Obligation (PBO) [year-end] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9,658 | +7.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 8,964 | -6.1% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 9,544 | +11.1% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 8,588 | -28.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 12,006 | +1.8% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 11,792 | +36.4% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 8,646 | +30.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 6,618 | -5.3% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 6,985 | +19.8% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 5,829 | +8.2% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 5,387 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up defined Benefit Pension Plans
- Accumulated Benefit Obligation (ABO) [year-end] ($M)8,700 · FY2025
- Fair Value of Pension Plan Assets [year-end] ($M)12,204 · FY2025
- Pension Funded Status [year-end] ($M)2,546 · FY2025
- Pension Noncurrent Assets Recognized on Balance Sheet ($M)3,196 · FY2025
- Pension Current Liabilities Recognized on Balance Sheet ($M)23 · FY2025
- Pension Noncurrent Liabilities Recognized on Balance Sheet ($M)627 · FY2025
- Net Periodic Pension Benefit Cost ($M)-53 · FY2025
- Pension Service Cost ($M)264 · FY2025
- Pension Interest Cost ($M)484 · FY2025
- Expected Return on Pension Plan Assets ($M)832 · FY2025
- Actual Return on Pension Plan Assets [annual] ($M)1,434 · FY2025
- Employer Pension Contributions [annual] ($M)348 · FY2025
- Pension Benefits Paid [annual] ($M)371 · FY2025
- Pension Benefit Obligation Weighted-Average Discount Rate (%)5.5% · FY2025
- Expected Long-Term Rate of Return on Pension Plan Assets (%)7.6% · FY2025
Cite this data
StockData. (2026). AbbVie Defined Benefit Pension Plans ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/db-pension-pbo
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.